Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Anti-CD45 monoclonal antibody (MAb) dose optimization for astatine-211 (211At)-radioimmunotherapy (RIT) of relapsed non-Hodgkin lymphoma (NHL) in a canine model
The Journal of Nuclear Medicine (2014)
  • Sofia Frost, Fred Hutchinson Cancer Research Center
  • Brian Miller, Pacific Northwest National Laboratory
  • Tom Back, University of Gothenburg
  • Erlinda Santos, Fred Hutchinson Cancer Research Center
  • Donald Hamlin, University of Washington
  • Oliver Press, Fred Hutchinson Cancer Research Center
  • Rainer Storb, Fred Hutchinson Cancer Research Center
  • D. Scott Wilbur, University of Washington
  • Brenda Sandmaier, Fred Hutchinson Cancer Research Center
  • John Pagel, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
May 1, 2014
Citation Information
Sofia Frost, Brian Miller, Tom Back, Erlinda Santos, et al.. "Anti-CD45 monoclonal antibody (MAb) dose optimization for astatine-211 (211At)-radioimmunotherapy (RIT) of relapsed non-Hodgkin lymphoma (NHL) in a canine model" The Journal of Nuclear Medicine Vol. 55 (2014) p. 637 - 637
Available at: http://works.bepress.com/john-pagel/99/